EUVIMEDEUVIMED entdecken
Crossref

Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity

Xiaofei Wang, Zijing Wang, Jingya Wang, Yihang Yu, Yiting Wang, Zaihuan Xiong, Shengna Han, Xiao-Bo Zhong, Pei Wang, Lirong Zhang

Molecular Pharmacology · 2025

DOI: 10.1016/j.molpha.2025.100021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Xiaofei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Sciences, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, China; Department of Pharmacology,…. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, Ritonavir, Ubiquitination, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ritonavir (RTV) is an important drug for anti-human immunodeficiency virus treatment and is mainly metabolized by cytochrome P450 (CYP) 3A4. Clinically, the most common side effect of RTV treatment is hepatoxicity. We previously showed that the long noncoding RNA hepatocyte nuclear factor 4 alpha (HNF4A) antisense 1 (HNF4A-AS1) negatively regulated CYP3A4 expression and participated in RTV-induced hepatotoxicity in vitro, but the mechanism has not been well understood. In this study, similar results were observed in the mouse, where liver-specific knockdown of Hnf4aos (homolog of human HNF4A-AS1) led to increased serum aspartate (∼1.8-fold) and alanine transaminase (∼2.4-fold) levels and enlarged and degenerated hepatocytes 24 hours after RTV administration. Meanwhile, endoplasmic reticulum stress markers GRP78, PDI, and XBP-1 increased about 2.4-fold, 2.1-fold, and 2.7-fold, respectively. The aggravated liver injury correlated with Hnf4aos knockdown, attributable to heightened Cyp3a11 (homolog of human CYP3A4) expression (mRNA and protein levels were 1.8-fold and 2.5-fold, respectively). Importantly, in vitro studies revealed the underlying mechanism that HNF4A-AS1 mediated the interaction between heterogeneous nuclear ribonucleoprotein C and HNF4A, whereas heterogeneous nuclear ribonucleoprotein C promoted HNF4A degradation through the ubiquitination pathway, thereby decreasing CYP3A4 expression and alleviating RTV-induced liver injury. Overall, our findings unveil a novel mechanism by which HNF4A-AS1 regulates CYP3A4 expression to influence RTV-induced liver injury. SIGNIFICANCE STATEMENT: HNF4A-AS1 negatively regulates the expression of CYP3A4, whose overexpression is highly correlated with ritonavir (RTV)-induced liver injury. In this study, the role of Hnf4aos (homolog of human HNF4A-AS1) in RTV-induced hepatotoxicity was confirmed in mice. We found that HNF4A-AS1 and HNRNPC form a complex and facilitate the ubiquitination and degradation of HNF4A protein, thereby decreasing CYP3A4 expression and alleviating RTV hepatotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 4RitonavirUbiquitinationChemical and Drug Induced Liver InjuryRNA, Long NoncodingAnimalsMiceHumansCytochrome P-450 CYP3AMaleEndoplasmic Reticulum Chaperone BiPMice, Inbred C57BLLiverHepatocytesEndoplasmic Reticulum StressHep G2 Cells

Stichwörter der Autor:innen

Cytochrome P450 3A4HNF4A-AS1Hepatocyte nuclear factor 4AHepatotoxicityRitonavir

Substanzen

Hepatocyte Nuclear Factor 4RitonavirCytochrome P-450 CYP3AHspa5 protein, mouseHnf4a protein, mouseEndoplasmic Reticulum Chaperone BiPRNA, Long NoncodingHSPA5 protein, humanHNF4A protein, human

Autor:innen und Institutionen

  • Academy of Medical Sciences, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, China; Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmac…
  • Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, China.
  • Department of Clinical Pharmacology, School of Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut.
  • Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, China. Electronic address: peiwang0707@zzu.edu.cn.
  • Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, China. Electronic address: lrzhang@zzu.edu.cn.

Förderung

  • Natural Science Foundation of Henan Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Wang, Z., Wang, J., Yu, Y., Wang, Y., Xiong, Z., Han, S., Zhong, X. B., Wang, P., & Zhang, L. (2025). Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100021

Vancouver

Wang X, Wang Z, Wang J, Yu Y, Wang Y, Xiong Z, et al. Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100021

BibTeX
@article{Wang2025,
  author = {Wang, Xiaofei and Wang, Zijing and Wang, Jingya and Yu, Yihang and Wang, Yiting and Xiong, Zaihuan and Han, Shengna and Zhong, Xiao-Bo and Wang, Pei and Zhang, Lirong},
  title = {Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity},
  journal = {Molecular Pharmacology},
  year = {2025},
  doi = {10.1016/j.molpha.2025.100021}
}
Kostenlos starten →